Computational Analysis of Lianhua Qingwen as an Adjuvant Treatment in Patients with COVID-19
Wang et al., Society of Toxicology Conference, 2023
Wang et al., Computational Analysis of Lianhua Qingwen as an Adjuvant Treatment in Patients with COVID-19, Society of Toxicology Conference, 2023
In Silico analysis of components of Lianhua Qingwen, identifying quercetin, luteolin, wogonin, and phillyrin as potentially beneficial for COVID-19. Authors note that quercetin bound to Mpro at the same inhibitory pocket as nirmatrelvir (paxlovid).
Wang et al., 31 Mar 2023, peer-reviewed, 5 authors.
In Silico studies are an important part of preclinical research, however results may be very different in vivo.